195 related articles for article (PubMed ID: 27139150)
1. Interobserver Variability in the Diagnosis of Uterine High-Grade Endometrioid Carcinoma.
Thomas S; Hussein Y; Bandyopadhyay S; Cote M; Hassan O; Abdulfatah E; Alosh B; Guan H; Soslow RA; Ali-Fehmi R
Arch Pathol Lab Med; 2016 Aug; 140(8):836-43. PubMed ID: 27139150
[TBL] [Abstract][Full Text] [Related]
2. The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
Hussein YR; Broaddus R; Weigelt B; Levine DA; Soslow RA
Int J Gynecol Pathol; 2016 Jan; 35(1):16-24. PubMed ID: 26166718
[TBL] [Abstract][Full Text] [Related]
3. Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma.
Gilks CB; Oliva E; Soslow RA
Am J Surg Pathol; 2013 Jun; 37(6):874-81. PubMed ID: 23629444
[TBL] [Abstract][Full Text] [Related]
4. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
5. The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features.
Fadare O; Parkash V; Dupont WD; Acs G; Atkins KA; Irving JA; Pirog EC; Quade BJ; Quddus MR; Rabban JT; Vang R; Hecht JL
Am J Surg Pathol; 2012 Aug; 36(8):1107-18. PubMed ID: 22790851
[TBL] [Abstract][Full Text] [Related]
6. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.
Lax SF; Kurman RJ; Pizer ES; Wu L; Ronnett BM
Am J Surg Pathol; 2000 Sep; 24(9):1201-8. PubMed ID: 10976693
[TBL] [Abstract][Full Text] [Related]
7. Architectural versus nuclear atypia-defined FIGO grade 2 endometrial endometrioid adenocarcinoma (EEC): a clinicopathologic comparison of 154 cases with clinical follow-up.
Winham WM; Lin D; Stone PJ; Nucci MR; Quick CM
Int J Gynecol Pathol; 2014 Mar; 33(2):120-6. PubMed ID: 24487465
[TBL] [Abstract][Full Text] [Related]
8. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG
Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
[TBL] [Abstract][Full Text] [Related]
9. High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases.
Assem H; Rambau PF; Lee S; Ogilvie T; Sienko A; Kelemen LE; Köbel M
Am J Surg Pathol; 2018 Apr; 42(4):534-544. PubMed ID: 29309296
[TBL] [Abstract][Full Text] [Related]
10. Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation.
Ussakli C; Usubutun A; Dincer N; Dolgun A; Bülbül D; Isikdogan Z; Haberal N; Ozen O; Tezel GG
Pol J Pathol; 2016; 67(3):221-227. PubMed ID: 28155970
[TBL] [Abstract][Full Text] [Related]
11. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
Rabban JT; Gilks CB; Malpica A; Matias-Guiu X; Mittal K; Mutter GL; Oliva E; Parkash V; Ronnett BM; Staats P; Stewart CJR; McCluggage WG
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S25-S39. PubMed ID: 30550482
[TBL] [Abstract][Full Text] [Related]
12. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
[TBL] [Abstract][Full Text] [Related]
13. Pap smears in women with endometrial carcinoma.
Gu M; Shi W; Barakat RR; Thaler HT; Saigo PE
Acta Cytol; 2001; 45(4):555-60. PubMed ID: 11480718
[TBL] [Abstract][Full Text] [Related]
14. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
[TBL] [Abstract][Full Text] [Related]
15. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
Boruta DM; Gehrig PA; Groben PA; Bae-Jump V; Boggess JF; Fowler WC; Van Le L
Cancer; 2004 Nov; 101(10):2214-21. PubMed ID: 15452833
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
Schlosshauer PW; Ellenson LH; Soslow RA
Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
18. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
[TBL] [Abstract][Full Text] [Related]
19. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
Bartosch C; Manuel Lopes J; Oliva E
Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
[TBL] [Abstract][Full Text] [Related]
20. A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system.
Kim HJ; Kim TJ; Lee YY; Choi CH; Lee JW; Bae DS; Kim BG
J Gynecol Oncol; 2013 Apr; 24(2):120-7. PubMed ID: 23653828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]